Fecal Microbiota Transplant National Registry | MicrobiomeTrials← Back to trialsNCT03325855
Fecal Microbiota Transplant National Registry
RecruitingOBSERVATIONAL
Trial Details
Start: 2017-09-20Est. Completion: 2027-08
Enrollment target: 4,000 participants Locations- Phoenix Children's Hospital, Phoenix, Arizona, United States
- Children's Hospital of Los Angeles, Los Angeles, California, United States
- University of California, Los Angeles, California, United States
- Stanford University, Redwood City, California, United States
- Sutter Roseville Medical Center, Roseville, California, United States
- University of California San Francisco, San Francisco, California, United States
- Ventura Clinical Trials, Ventura, California, United States
- Yale New Haven Hospital, Hamden, Connecticut, United States
- MedStar Georgetown University Hospital, Georgetown, District of Columbia, United States
- Best Quality Research, Inc., Hialeah, Florida, United States
- University of Miami, Miller School of Medicine, Miami, Florida, United States
- GI Pros, Naples, Florida, United States
- Emory University School of Medicine, Atlanta, Georgia, United States
- The University of Chicago, Chicago, Illinois, United States
- University of Chicago School of Medicine, Chicago, Illinois, United States
- NorthShore University Health System, Evanston, Illinois, United States
- Loyola University Medical Center, Maywood, Illinois, United States
- Loyola University of Chicago/ Loyola University Medical Center, Maywood, Illinois, United States
- Carle Foundation Hospital, Urbana, Illinois, United States
- Indiana University School of Medicine, Indianapolis, Indiana, United States
- University of Kansas Medical Center Research Institute, Kansas City, Kansas, United States
- Ochsner, New Orleans, Louisiana, United States
- Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
- American Gastroenterological Association, Bethesda, Maryland, United States
- Boston Children's Hospital, Boston, Massachusetts, United States
Other microbiome trials you might be interested in
Autism Spectrum Disorder
This is a single-center, randomized, double-dummy, triple-blind, placebo-controlled, three-arm parallel-group superiorit…
Shenzhen, ChinaEst. completion Dec 31, 2026
Acute Leukemia in RemissionMyelodysplastic SyndromesMyeloproliferative SyndromeHodgkin LymphomaLymphoma, Non-HodgkinMyelomaChronic Lymphocytic Leukemia
The aim of this study is to assess the Fecal Microbiota Transplantation (FMT) efficacy in the prevention of allogeneic h…
Brigham and Women's Hospital, Boston, Massachusetts, United StatesUMass Memorial Health, Worcester, Massachusetts, United StatesSt. Joseph Mercy Hospital, Ann Arbor, Michigan, United StatesUniversity of Michigan, Ann Arbor, Michigan, United StatesHenry Ford Health Hospital, Detroit, Michigan, United StatesMayo Clinic - Division of Pediatric Gastroenterology, Rochester, Minnesota, United StatesMayo Clinic, Rochester, Minnesota, United StatesValley Hospital and Medical Center, Las Vegas, Nevada, United StatesAtlantic Health System, Morristown, New Jersey, United StatesRutgers, New Brunswick, New Jersey, United StatesPenn Medicine Princeton Health, Plainsboro, New Jersey, United StatesConcorde Medical Group, New York, New York, United StatesNew York University School of Medicine, New York, New York, United StatesWeill Cornell Medicine - Pediatric, New York, New York, United StatesWeill Cornell Medicine, New York, New York, United StatesIcahn School of Medicine at Mount Sinai, New York, New York, United StatesGastroenterology Group of Rochester, LLP, Rochester, New York, United StatesUniversity of North Carolina, Chapel Hill, North Carolina, United StatesOregon Health & Science University, Portland, Oregon, United StatesTemple University, Philadelphia, Pennsylvania, United StatesBrown University Women's Medicine and Collaborative, Providence, Rhode Island, United StatesVanderbilt University Medical Center, Nashville, Tennessee, United StatesTexas Children's Hospital / Baylor College of Medicine, Houston, Texas, United StatesBaylor Research Institute - Scott & White Medical Center, Temple, Texas, United StatesWest Virginia University, Morgantown, West Virginia, United StatesUniversity of Wisconsin - Madison, Madison, Wisconsin, United StatesThe Medical College of Wisconsin, Milwaukee, Wisconsin, United StatesUniversity of Alberta, Edmonton, Alberta, CanadaAmiens, France
Est. completion May 2030
Head and Neck Squamous Cell Carcinoma
This is a single-centre feasibility study designed to assess the safety, tolerability and engraftment of MET-4 bacterial…
Toronto, CanadaCompleted Sep 16, 2025